Carlos V. Paya

Insider Reports History

Location
C/O Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle, WA
Signature
Carlos V. Paya, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carlos V. Paya:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COLLEGIUM PHARMACEUTICAL, INC Director Common Stock 19.6K $524K $26.78 May 15, 2025 Direct
STANDARD BIOTOOLS INC. Director Common Stock 127K $322K $2.54 Jun 14, 2023 Direct
Vaxcyte, Inc. Director Common Stock 5.63K $163K $29.00 Jun 12, 2025 By Family Trust
Vaxcyte, Inc. Director Common Stock 4.59K $133K $29.00 Jun 12, 2025 Direct
STANDARD BIOTOOLS INC. Director Stock Option (Right to Buy) 35.4K $65.8K $1.86 Jun 14, 2023 Direct
Vaxcyte, Inc. Director Stock Option (right to buy) 15.4K Jun 12, 2025 Direct
Vaxcyte, Inc. Director Stock Option (right to buy) 7.25K Dec 9, 2024 By Family Trust

Insider Reports Filed by Carlos V. Paya

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCVX Vaxcyte, Inc. Jun 12, 2025 2 $0 4 Jun 16, 2025 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 15, 2025 1 $0 4 May 19, 2025 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 15, 2025 0 $0 3 May 19, 2025 Director
PCVX Vaxcyte, Inc. Dec 6, 2024 4 $0 4 Dec 10, 2024 Director
PCVX Vaxcyte, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
PCVX Vaxcyte, Inc. Nov 9, 2023 8 $0 4 Nov 9, 2023 Director
LAB STANDARD BIOTOOLS INC. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
PCVX Vaxcyte, Inc. Jun 13, 2023 2 $0 4 Jun 15, 2023 Director
MNKTQ Mallinckrodt plc Jun 16, 2022 0 $0 4 Jun 21, 2022 Director
LAB STANDARD BIOTOOLS INC. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
PCVX Vaxcyte, Inc. Jun 1, 2022 2 $0 4 Jun 3, 2022 Director
PCVX Vaxcyte, Inc. Oct 27, 2021 1 $0 4 Oct 29, 2021 Director
PCVX Vaxcyte, Inc. Oct 27, 2021 0 $0 3 Oct 29, 2021 Director
LAB FLUIDIGM CORP May 25, 2021 2 $0 4 May 27, 2021 Director